Thomas E. Timbie has served as a member of our board of directors since June 2014 and served as our Chief Financial Officer from July 2014 to October 2015. Mr. Timbie is the President of Timbie & Company, LLC, a financial and management consulting firm he founded in 2000. Mr. Timbie has over 30 years of financial experience primarily in the medical device market. During 2005, as the interim Chief Financial Officer of ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT), Mr. Timbie helped lead ev3 through their initial public offering. He was also the Chief Financial Officer of Xomed Surgical Products, Inc., including during its initial public offering in 1996, and continuing in that role until Xomed was acquired by Medtronic plc (NYSE: MDT) in 1999. Prior to Xomed, Mr. Timbie was the Chief Financial Officer of TreBay Medical Corp., a private orthopaedic and microsurgical device company, and the Director of Accounting at Concept Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (NYSE: CNMD). Timbie has also previously served as a member of the board of directors of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., until its acquisition by Covidien (part of Medtronic plc. (NYSE: MDT)); and American Medical Systems, Inc., now part of Endo Pharmaceuticals (NASDAQ: ENDP). Mr. Timbie holds a B.S. in Accounting from University of Florida, an M.B.A. from Stetson University and is a certified public accountant (current status inactive). Mr. Timbie has also served as a board member and audit committee chairman of several public and private medical device companies including Wright Medical, Inc. acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT); Acclarent, Inc., acquired by Johnson & Johnson (NYSE: JNJ) in 2010; and American Medical Systems, Inc. acquired by Endo Pharmaceuticals (NASDAQ: ENDP) in 2011. Mr. Timbie is also a former board member and audit committee chairman of two health care services companies, LaVie Care Centers and RegionalCare Hospital Partners.
What is Thomas E. Timbie's net worth?
The estimated net worth of Thomas E. Timbie is at least $8.74 million as of March 15th, 2023. Mr. Timbie owns 1,149,069 shares of Treace Medical Concepts stock worth more than $8,744,415 as of November 16th. This net worth estimate does not reflect any other assets that Mr. Timbie may own. Learn More about Thomas E. Timbie's net worth.
How do I contact Thomas E. Timbie?
Has Thomas E. Timbie been buying or selling shares of Treace Medical Concepts?
Thomas E. Timbie has not been actively trading shares of Treace Medical Concepts during the last quarter. Most recently, Thomas E. Timbie sold 50,000 shares of the business's stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $23.03, for a transaction totalling $1,151,500.00. Following the completion of the sale, the director now directly owns 1,149,069 shares of the company's stock, valued at $26,463,059.07. Learn More on Thomas E. Timbie's trading history.
Who are Treace Medical Concepts' active insiders?
Are insiders buying or selling shares of Treace Medical Concepts?
During the last twelve months, Treace Medical Concepts insiders bought shares 12 times. They purchased a total of 812,902 shares worth more than $4,206,561.76. The most recent insider tranaction occured on September, 16th when CEO John T Treace bought 50,000 shares worth more than $265,500.00. Insiders at Treace Medical Concepts own 24.4% of the company.
Learn More about insider trades at Treace Medical Concepts. Information on this page was last updated on 9/16/2024.
